Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03970616 |
Title | A Study of Tivozanib in Combination With Durvalumab in Subjects With Untreated Advanced Hepatocellular Carcinoma |
Acronym | DEDUCTIVE |
Recruitment | Terminated |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | AVEO Pharmaceuticals, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Banner MD Anderson Cancer Center | Gilbert | Arizona | 85234 | United States | Details | |
City of Hope | Duarte | California | 91010 | United States | Details | |
University of California - Irvine | Orange | California | 92868 | United States | Details | |
Northwestern University Feinberg School of Medicine | Chicago | Illinois | 60611 | United States | Details | |
Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
Montefiore Medical Center | Bronx | New York | 10467 | United States | Details | |
Roswell Park Cancer Institute | Buffalo | New York | 14263 | United States | Details | |
UT Southwestern Medical Center | Dallas | Texas | 75390 | United States | Details | |
The University of Texas Health Science Center at Houston (UTHealth) | Houston | Texas | 77030 | United States | Details | |
The University of Texas Health Science Center at Tyler (UTHealth) | Tyler | Texas | 75708 | United States | Details |